InsiderClue
Stocks · Health care · Pharmaceutical Preparations

NewAmsterdam Pharma Co N.V.

NAMS Clue Score24
Netherlands Fiscal year ends December CIK 0001936258
$21.58 +1.48% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $21.58 +178.39% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 23 Nov 2022. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Operating income−5.4Net income−5.7EPS, diluted−0.62Fiscal year 2021Operating income−35.0Net income−41.8EPS, diluted−3.81Fiscal year 2022Revenue102.7Operating income−3.6Net income−22.6EPS, diluted−1.19Fiscal year 2023Revenue14.1 −86.3%Operating income−183.0Net income−176.9EPS, diluted−2.15Fiscal year 2024Revenue45.6 +223.4%Operating income−176.3Net income−241.6EPS, diluted−2.56Fiscal year 2025Revenue22.5 −50.6%Operating income−225.7Net income−203.8EPS, diluted−1.72
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a 102.7 14.1 45.6 22.5
Growth −86.3% +223.4% −50.6%
Operating income −5.4 −35.0 −3.6 −183.0 −176.3 −225.7
Net income −5.7 −41.8 −22.6 −176.9 −241.6 −203.8
Growth
EPS, diluted −0.62 −3.81 −1.19 −2.15 −2.56 −1.72

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2020Fiscal year 2021Fiscal year 2022Operating margin−3.5%Net margin−22.0%Free cash flow margin10.2%Fiscal year 2023Operating margin−1,298.6%Net margin−1,255.8%Free cash flow margin−1,002.4%Fiscal year 2024Operating margin−386.9%Net margin−530.3%Free cash flow margin−349.5%Fiscal year 2025Operating margin−1,002.9%Net margin−905.7%Free cash flow margin−657.8%
FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a −3.5% −1,298.6% −386.9% −1,002.9%
Net margin n/a n/a −22.0% −1,255.8% −530.3% −905.7%
Free cash flow margin n/a n/a 10.2% −1,002.4% −349.5% −657.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−6.0Capital expenditure−0.0Free cash flow−6.0Fiscal year 2021Operating cash flow−29.5Capital expenditure−0.0Free cash flow−29.5Fiscal year 2022Operating cash flow10.7Capital expenditure−0.2Free cash flow10.4Fiscal year 2023Operating cash flow−141.2Capital expenditure−0.0Free cash flow−141.2 −1,452.4%Fiscal year 2024Operating cash flow−158.6Capital expenditure−0.7Free cash flow−159.2Fiscal year 2025Operating cash flow−147.8Capital expenditure−0.2Free cash flow−148.0
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −6.0 −29.5 10.7 −141.2 −158.6 −147.8
Capital expenditure −0.0 −0.0 −0.2 −0.0 −0.7 −0.2
Free cash flow −6.0 −29.5 10.4 −141.2 −159.2 −148.0
Growth −1,452.4%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2020Cash7.9Shareholders’ equity−73.0Fiscal year 2021Cash53.1Shareholders’ equity−113.8Fiscal year 2022Cash438.5Shareholders’ equity430.1Fiscal year 2023Cash340.5Shareholders’ equity288.4Fiscal year 2024Cash771.7Shareholders’ equity757.5Fiscal year 2025Cash490.0Shareholders’ equity683.4
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 7.9 53.1 438.5 340.5 771.7 490.0
Shareholders’ equity −73.0 −113.8 430.1 288.4 757.5 683.4

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022† 31 Dec 2022 FY2023† 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a n/a 102.7 14.1 45.6 22.5
Growth −86.3% +223.4% −50.6%
4.0 25.0 82.2 n/a n/a n/a
1.4 4.8 22.2 16.3 14.4 15.4
−5.4 −35.0 −3.6 −183.0 −176.3 −225.7
Growth
−5.7 −41.8 −22.6 −176.9 −241.6 −203.8
n/a n/a n/a 0.0 −0.0 n/a
−5.7 −41.8 −22.6 −176.9 −241.6 −203.8
Growth
Per share
−0.62 −3.81 −1.19 −2.15 −2.56 −1.72
−0.62 −3.81 −1.19 −2.15 −2.56 −1.72
Growth
9.2 11.0 19.0 82.2 94.4 118.4
4.3 11.0 19.0 82.2 94.4 118.4
Growth +153.9% +72.8% +333.2% +14.8% +25.5%

† The diluted share count jumps at 2021 and 2022 and 2023, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 6 of 6 years on file.